Herceptin Hylecta Injection, Solution
Product Images NDC 50242-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Herceptin Hylecta (NDC 50242-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Herceptin 01)

Figure 1 (Herceptin 01)
Not available.*
FDA Label Image

Figure 2 (Herceptin 02)

Figure 2 (Herceptin 02)
FDA Label Image

Figure 3 (Herceptin 03)

Figure 3 (Herceptin 03)
FDA Label Image

Principal Display Panel (600 mg/10,000 unit Vial Carton)

Principal Display Panel (600 mg/10,000 unit Vial Carton)
NDC 50242-077-01 is a single-dose injectable medication called Herceptin Hylecta™ which contains trastuzumab and hyaluronidase-oysk. It is intended for subcutaneous use only and any unused portion should be discarded. This medication is manufactured by Genentech and comes in a single vial.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.